The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -0.11 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -2.63 — no flag raisedOK
- Earnings quality 82/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Apyx Medical Corp reports it. History and quarterly detail are in the app.
- Surgical Aesthetics$45.3M
- OEM$7.5M
Leadership changes
From Apyx Medical Corp's own filings, the day they're filed.
- Shawn Roman · Chief Operating Officer · appointmenteff. 2025-01-28
- Andrew Makrides · Chairman · departureeff. 2024-05-07
- Stavros G. Vizirgianakis · Chairman · departureeff. 2024-05-07
Latest filings
- 8-K · Company announcement2026-05-21
- 8-K · Company announcement2026-05-14
- 8-K · Company announcement2026-05-11
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Apyx Medical Corp, every answer cited🔒
- The Intelligence Brief — added when Apyx Medical Corp's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.